ICAAC update.
Coppedge
B
B
D000081:Acetamides; D000098:Acetophenones; D019380:Anti-HIV Agents / Q000008:administration & dosage*; D018791:CD4 Lymphocyte Count / Q000187:drug effects; D002219:Carbamates; D002986:Clinical Trials as Topic; D018450:Disease Progression; D004359:Drug Therapy, Combination; D015507:Drugs, Investigational; D005663:Furans; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000008:administration & dosage* / Q000494:pharmacology; D006801:Humans; D019259:Lamivudine / Q000008:administration & dosage; D018894:Reverse Transcriptase Inhibitors / Q000008:administration & dosage*; D019438:Ritonavir / Q000008:administration & dosage; D019258:Saquinavir / Q000008:administration & dosage; D013449:Sulfonamides / Q000008:administration & dosage / Q000494:pharmacology; D019562:Viral Load
D000081:Acetamides; D000098:Acetophenones; D019380:Anti-HIV Agents; D002219:Carbamates; D015507:Drugs, Investigational; D005663:Furans; D017320:HIV Protease Inhibitors; D018894:Reverse Transcriptase Inhibitors; D013449:Sulfonamides; D019259:Lamivudine; C080073:loviride; C095108:amprenavir; D019258:Saquinavir; D019438:Ritonavir